Laboratoires Delbert

Laboratoires Delbert, operating under the brand name DELBERT Pharma, is a French pharmaceutical company specializing in the acquisition, safeguarding, and distribution of essential off-patent medicines facing supply shortages or discontinuation. Headquartered in Paris, France, the company focuses on therapeutic areas including infectiology, pneumology, oncology, hematology, and neurology. DELBERT Pharma buys marketing authorizations for mature critical drugs and works to relocate their production to France and Europe. Its product portfolio features essential hospital and retail pharmaceutical specialties such as antibiotics, injectable drugs, lithium carbonate, aztreonam, amoxicillin, and tropatepine. Recognized as a mission-driven company under French law, the laboratory serves healthcare professionals, hospital pharmacists, and distributors across Europe and international markets. The organization integrates end-to-end supply chain processes including inventory management, logistics, quality management, and regulatory affairs compliance under European Good Manufacturing Practices. By repositioning existing active pharmaceutical ingredients for rare disease indications, the firm ensures uninterrupted treatment availability for patients with unmet medical needs.